my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
09-13-2006: Atrium Biotechnologies Inc. announced the acquisition of the assets of London, Ontario based Douglas Laboratories Canada ("DL Canada"). DL Canada has been marketing Douglas Laboratories products in Canada since 2000 and has current annual revenues of approximately $5 million.
"This acquisition provides Atrium with a platform to develop the Canadian healthcare professional market not only for the Douglas Laboratories brand but also for the Pure Encapsulations brand which is not currently being sold in Canada. This acquisition further reinforces our current leadership position in North America and marks another step in our strategy to control access to markets and build solid organic growth for our brands," stated Richard Bordeleau, President of Atrium's Health & Nutrition Division.
In addition, Atrium will be able to benefit from the expertise and support of DL Canada's current management and staff who are staying on to ensure the successful integration and to sustain its growth.
Watchlist
This is where you can add this news to your personal favourites
Atrium Acquires AquaCap for $21.5 million
Atrium Biotechnologies Inc. announced that it acquired, effective January 19, 2007, Philadelphia area-based AquaCap Pharmaceutical, Inc. ("AquaCap"), developer and manufacturer of liquid filled capsules within the nutritional supplement industry in the United States. This novel technology s ... more
AEterna Zentaris Completes Distribution of Remaining Shares of Atrium Biotechnologies
AEterna Zentaris Inc. announced that it has completed the special distribution in kind of all of the 11,052,996 subordinate voting shares of the capital of Atrium Biotechnologies Inc. previously held by AEterna Zentaris by way of return of capital that was approved at the Company's special ... more
Atrium acquires Douglas Laboratories Canada
Atrium Biotechnologies Inc. announced the acquisition of the assets of London, Ontario based Douglas Laboratories Canada ("DL Canada"). DL Canada has been marketing Douglas Laboratories products in Canada since 2000 and has current annual revenues of approximately $5 million. "This acquisi ... more
Atrium acquires Douglas Laboratories Canada
Atrium Biotechnologies Inc. announced the acquisition of the assets of London, Ontario based Douglas Laboratories Canada ("DL Canada"). DL Canada has been marketing Douglas Laboratories products in Canada since 2000 and has current annual revenues of approximately $5 million. "This acquisi ... more
Atrium acquires Douglas Laboratories
Atrium Biotechnologies Inc. announced the acquisition of Pittsburgh-based HVL Inc. ("Douglas") whose main brand is Douglas Laboratories. Douglas has been marketing health and nutritional products through healthcare practitioners for over 50 years and has current annual revenues of approxima ... more
About CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2012 CHEMIE.DE Information Service GmbH, All rights reserved
